The NIH has selected OMRF to lead a $58.5 million public-private partnership aimed at developing more effective treatments for autoimmune diseases.
James
Life Changer: Oklahoma’s lupus cohort marks 20 years
Oklahoma’s lupus cohort marks 20 years.
OMRF experts recommend flu shot before October ends
In this year of Covid-19 vaccines, don’t forget about your annual flu shot.
A Time of Growth
When Dr. William Thurman, above, took the helm of OMRF, he brought the lab coat he’d worn since his days training as a pediatric oncologist. That powder-blue garment, along with the bow ties he favored, would become synonymous with OMRF throughout the 1980s (and most of the 1990s). But his sartorial flourishes would prove the […]
Searching for answers with a third-dose trial
Who should get a third dose of Covid-19 vaccine?
2020 Annual Report: A Homecoming of Sorts
When Dr. Matlock Jeffries began his first day of work at OMRF in August, it may have been the smoothest transition in the foundation’s history. That Monday morning, he entered the same lab where he’d been studying osteoarthritis for the previous four years. Only now, he’d be doing it as a member of OMRF’s scientific […]
